tradmap

BIAF Earnings bioAffinity Technologies, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$23 -$11 $0 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $5M $9M 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$15M -$7M $0 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$16 -$8 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $1M $2M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$5M -$3M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–17 of 17
Q2 20262026-06-30-1.442026-08-0710-Q
Q1 20262026-03-31-0.812026-05-1110-Q
FY 20252025-12-31-8.662026-03-1610-K
Q3 20252025-09-30-7.552025-11-1410-Q
Q2 20262025-06-30-10.012026-08-0710-Q
Q1 20262025-03-31-4.802026-05-1110-Q
FY 20252024-12-31-22.502026-03-1610-K
Q3 20252024-09-30-16.222025-11-1410-Q
Q2 20252024-06-30-0.382025-08-1410-Q
Q1 20252024-03-31-0.202025-05-1510-Q
FY 20242023-12-31-0.912025-03-3110-K
Q3 20242023-09-30-0.652024-11-1410-Q
Q2 20242023-06-30-0.382024-08-1410-Q
Q1 20242023-03-31-0.182024-05-1510-Q
FY 20232022-12-31-1.812024-04-0110-K
Q3 20232022-09-30-2.032023-11-1410-Q
Q2 20232022-06-30-0.582023-08-1410-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.